Clinical Trial Update: Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia [Phase 2]

View source ↗

Summary

Phase 2 trial update for timolol gel addressing epistaxis in hereditary hemorrhagic telangiectasia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• Timolol gel (timolol)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hereditary Hemorrhagic Telangiectasia | Phase 2 | Status: COMPLETED | Results posted: 2021-08-24